Spero Therapeutics
SPRO
$1.22
Share price
-10.88%
Change (1 day)
-53.82%
Change (1 year)
Categories
Earnings for Spero Therapeutics (SPRO)
Earnings in 2024 (TTM): -A$1.11 Million
According to Spero Therapeutics's latest financial reports the company's current earnings are A$89.86 Million. In 2023 the company made an earning of A$44.25 Million, an increase over its 2022 earnings that were of -A$69.66 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Spero Therapeutics from 2017 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024 (TTM)  | -A$1.11 Million | -102.5% |
| 2023 | A$44.25 M | -163.53% |
| 2022 | -A$69.66 Million | -50.14% |
| 2021 | -A$0.14 Billion | 11.06% |
| 2020 | -A$0.13 Billion | 25.15% |
| 2019 | -A$0.11 Billion | 47.68% |
| 2018 | -A$68.07 Million | 5.61% |
| 2017 | -A$64.45 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | A$46.67 M | -50,715.52% | 🇺🇸 USA |
 | A$9.21 B | -9,994,927.59% | 🇺🇸 USA |
 | A$3.22 B | -3,498,375.86% | 🇨🇦 Canada |